| Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme ZC Elmore, DK Oh, KE Simon, MM Fanous, A Asokan JCI insight 5 (19), 2020 | 83 | 2020 |
| Engineering highly efficient backsplicing and translation of synthetic circRNAs RM Meganck, J Liu, AE Hale, KE Simon, MM Fanous, HA Vincent, ... Molecular Therapy-Nucleic Acids 23, 821-834, 2021 | 50 | 2021 |
| Coevolution of adeno-associated virus capsid antigenicity and tropism through a structure-guided approach LP Havlik, KE Simon, JK Smith, KA Klinc, LV Tse, DK Oh, MM Fanous, ... Journal of Virology 94 (19), 10.1128/jvi. 00976-20, 2020 | 43 | 2020 |
| Evaluation of pain assessment techniques and analgesia efficacy in a female guinea pig (Cavia porcellus) model of surgical pain VL Oliver, S Athavale, KE Simon, LV Kendall, JA Nemzek, JL Lofgren Journal of the American Association for Laboratory Animal Science 56 (4 …, 2017 | 31 | 2017 |
| Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing TJ Gonzalez, KE Simon, LO Blondel, MM Fanous, AL Roger, ... Nature communications 13 (1), 5947, 2022 | 28 | 2022 |
| Modulation of sialic acid dependence influences the central nervous system transduction profile of adeno-associated viruses BH Albright, KE Simon, M Pillai, GW Devlin, A Asokan Journal of Virology 93 (11), 10.1128/jvi. 00332-19, 2019 | 14 | 2019 |
| Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme. JCI Insight 5: e139881 ZC Elmore, DK Oh, KE Simon, MM Fanous, A Asokan | 5 | 2020 |
| Development and validation of a sleep questionnaire, SNoRE 3.0, to evaluate sleep in companion dogs A Mondino, C Ludwig, C Menchaca, K Russell, KE Simon, E Griffith, A Kis, ... Scientific Reports 13 (1), 13340, 2023 | 1 | 2023 |
| Rescuing AAV gene transfer from antibody neutralization with an IgG-degrading enzyme ZC Elmore, DK Oh, KE Simon, MM Fanous, A Asokan bioRxiv, 2020.05. 12.092122, 2020 | 1 | 2020 |
| Cross-Species Evolution of Synthetic AAV Strains for Clinical Translation TJ Gonzalez, LP Havlik, M Fanous, K Simon, L Edwards, J Kwon, ... Molecular Therapy 28 (4), 12-13, 2020 | 1 | 2020 |
| Feasibility of multispectral spin echo breast quantitative susceptibility mapping: an alternative to post-biopsy mammogram after MR-guided breast biopsy S Eskreis-Winkler, K Simon, Y Kee, J Cho, T Nguyen, P Spincemaille, ... | 1 | |
| A Randomized, Controlled Clinical Trial Demonstrates Improved Cognitive Function in Senior Dogs Supplemented with a Senolytic and NAD+ Precursor Combination. KE Simon, K Russell, A Mondino, CC Yang, BC Case, Z Anderson, ... bioRxiv, 2024.02. 26.581616, 2024 | | 2024 |
| Axillary lymphadenopathy on breast imaging following the administration of inactivated polio vaccine EG Lane, K Dodelzon, K Simon, K Babagbemi Clinical Imaging 95, 71-73, 2023 | | 2023 |
| Targeted In Vivo Manipulation of Murine T-Cells Using a Newly Evolved AAV Capsid Mutant JI Ark, W Nyberg, K Simon, A Rosales, S Clouden, J Eyquem, A Asokan MOLECULAR THERAPY 30 (4), 425-426, 2022 | | 2022 |
| A Novel Approach for Rapid and Transient Depletion of Pre-Existing Neutralizing Antibodies Against AAV Vectors Z Elmore, D Oh, K Simon, M Fanous, A Asokan MOLECULAR THERAPY 28 (4), 398-398, 2020 | | 2020 |
| Engineering A Humanized AAV8 Capsid through Iterative Structure-Guided Evolution LP Havlik, LV Tse, JK Smith, KA Klinc, D Oh, K Simon, W Shao, C Li, ... MOLECULAR THERAPY 27 (4), 53-53, 2019 | | 2019 |
